Your browser is no longer supported. Please, upgrade your browser.
Settings
MYOS MYOS RENS Technology Inc. daily Stock Chart
MYOS [NASD]
MYOS RENS Technology Inc.
Index- P/E- EPS (ttm)-0.45 Insider Own34.50% Shs Outstand9.72M Perf Week3.95%
Market Cap10.30M Forward P/E- EPS next Y- Insider Trans41.66% Shs Float5.51M Perf Month-11.54%
Income-4.10M PEG- EPS next Q- Inst Own5.50% Short Float0.96% Perf Quarter-18.58%
Sales1.20M P/S8.59 EPS this Y-7.10% Inst Trans-1.44% Short Ratio0.13 Perf Half Y-33.33%
Book/sh0.27 P/B3.41 EPS next Y- ROA-112.70% Target Price- Perf Year-25.20%
Cash/sh0.06 P/C14.72 EPS next 5Y- ROE-176.30% 52W Range0.74 - 1.80 Perf YTD-23.97%
Dividend- P/FCF- EPS past 5Y20.90% ROI-175.80% 52W High-48.89% Beta0.97
Dividend %- Quick Ratio1.00 Sales past 5Y-20.90% Gross Margin57.90% 52W Low24.12% ATR0.12
Employees15 Current Ratio2.90 Sales Q/Q200.00% Oper. Margin- RSI (14)45.80 Volatility7.07% 12.71%
OptionableNo Debt/Eq0.23 EPS Q/Q29.90% Profit Margin- Rel Volume0.14 Prev Close0.93
ShortableYes LT Debt/Eq0.00 EarningsMay 08 BMO Payout- Avg Volume421.87K Price0.92
Recom- SMA20-5.56% SMA50-7.49% SMA200-27.54% Volume57,302 Change-1.08%
Jun-04-20 08:00AM  
May-27-20 08:00AM  
May-21-20 08:00AM  
May-14-20 08:00AM  
May-13-20 03:19AM  
May-08-20 08:00AM  
May-04-20 08:00AM  
Apr-29-20 07:46AM  
Apr-28-20 08:00AM  
Apr-15-20 08:00AM  
Mar-30-20 02:26AM  
Mar-25-20 09:00AM  
06:00AM  
Mar-19-20 08:00AM  
Mar-12-20 08:00AM  
Mar-10-20 08:00AM  
Feb-06-20 10:08AM  
09:00AM  
Jan-30-20 07:00AM  
Jan-15-20 07:00AM  
Jan-09-20 07:00AM  
Dec-23-19 10:58AM  
Dec-17-19 07:00AM  
Dec-10-19 07:01AM  
Dec-02-19 09:27AM  
Nov-26-19 06:55AM  
Nov-20-19 07:27AM  
Nov-14-19 07:00AM  
Nov-07-19 05:14PM  
Nov-05-19 07:00AM  
Oct-31-19 06:00AM  
Oct-30-19 07:00AM  
Oct-23-19 10:59AM  
Oct-22-19 07:00AM  
Sep-17-19 10:58AM  
Sep-10-19 08:00AM  
Aug-29-19 01:30PM  
Aug-22-19 08:00AM  
Aug-12-19 03:14PM  
Aug-08-19 09:00AM  
Aug-06-19 08:09PM  
Jul-31-19 01:08PM  
Jul-08-19 02:37PM  
Jun-27-19 06:46AM  
Jun-20-19 03:15PM  
Jun-18-19 06:09PM  
05:46PM  
May-29-19 07:05AM  
May-23-19 10:10AM  
May-21-19 07:30AM  
May-08-19 06:00PM  
May-01-19 07:30AM  
Apr-04-19 05:45AM  
Apr-02-19 10:00AM  
Mar-28-19 06:00AM  
Mar-27-19 09:15PM  
Mar-26-19 07:30AM  
Feb-27-19 07:16AM  
Feb-21-19 07:16AM  
Feb-19-19 08:25AM  
Feb-07-19 07:30AM  
Jan-24-19 01:25PM  
Jan-23-19 08:00AM  
Jan-15-19 07:00AM  
Jan-08-19 06:05AM  
Jan-03-19 06:05AM  
Dec-25-18 11:42AM  
Dec-14-18 06:05AM  
Dec-13-18 04:05PM  
Dec-12-18 06:50AM  
Dec-11-18 12:11PM  
10:29AM  
06:05AM  
Dec-06-18 06:10AM  
Dec-04-18 03:30PM  
Nov-14-18 04:15PM  
Nov-08-18 06:10AM  
Nov-06-18 05:26PM  
Oct-16-18 08:20AM  
Oct-02-18 06:10AM  
Sep-26-18 07:00AM  
Sep-11-18 11:20AM  
Aug-17-18 02:00PM  
08:20AM  
Aug-08-18 05:39PM  
Aug-02-18 06:15AM  
Jul-12-18 08:00AM  
Jun-06-18 06:10AM  
May-31-18 07:55AM  
May-24-18 10:11AM  
May-16-18 09:45AM  
May-09-18 05:36PM  
May-03-18 08:02PM  
Apr-20-18 07:20AM  
Apr-12-18 10:00AM  
Apr-10-18 09:11AM  
06:10AM  
Apr-06-18 07:55AM  
Apr-03-18 03:15PM  
02:54PM  
MYOS RENS Technology Inc. focuses on the discovery, development, and commercialization of nutritional ingredients, functional foods, and other technologies that enhance muscle health and performance. The company primarily focuses on developing Fortetropin for the therapeutic markets, including the treatment of sarcopenia, cachexia, anorexia, obesity, and muscular disorders. Its products include Qurr line of products to support muscle well-being and fitness; Yolked line of products for collegiate and professional athletes; and Myos Canine Muscle Formula line of products for pets. The company sells its products through direct-to-consumer e-commerce platform. It has a research agreement with the University of California to study the effects Of Fortetropin on skeletal muscle protein synthetic rate in older men and women; Rutgers University for the discovery of compounds and products that improve muscle health and performance; Weill Cornell Medical College to study the efficacy of Fortetropin in preventing weight and muscle loss associated with cancer; and McMaster University to study impact of Fortetropin on muscle disuse atrophy in young men. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MATLIN DAVID J10% OwnerMar 06Buy1.21206,611249,9991,267,477Mar 10 04:19 PM
Mannello JosephChief Executive OfficerMar 05Buy1.21681,818825,0001,371,028Mar 09 05:05 PM
Dewey Christopher CDirectorMar 05Buy1.2182,645100,000322,371Mar 09 05:03 PM
PECHOCK CHRISTOPHERDirectorMar 05Buy1.2182,645100,000339,802Mar 09 05:04 PM
Ponte Andrew JoelDirectorMar 05Buy1.2182,645100,00094,193Mar 09 05:03 PM